Compounds of the formula: ##STR00001## or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ar, R.sup.1 and R.sup.2 are defined herein. Also provided are pharmaceutical compositions, methods of preparing the compounds, and method of using the compounds for treatment of monoamine reuptake inhibitor-mediated diseases.